Wayfinder Biosciences
Wayfinder Biosciences is a biotechnology company pioneering a new class of orally available small molecule therapeutics that target disease-causing proteins by binding to their mRNA, preventing protein production. Their proprietary platform integrates unique RNA-based sensors, experimental data, and AI/ML screening to discover selective, potent RNA-targeting small molecules. The company focuses on traditionally undruggable targets in oncology, neurodegeneration, immunology, and rare diseases, building a pipeline of small molecule assets. Their approach offers a scalable, quantitative method to modulate RNA targets, positioning them uniquely in the drug discovery market with a strong scientific advisory board and leadership team.
Wayfinder Biosciences
Wayfinder Biosciences is a biotechnology company pioneering a new class of orally available small molecule therapeutics that target disease-causing proteins by binding to their mRNA, preventing protein production. Their proprietary platform integrates unique RNA-based sensors, experimental data, and AI/ML screening to discover selective, potent RNA-targeting small molecules. The company focuses on traditionally undruggable targets in oncology, neurodegeneration, immunology, and rare diseases, building a pipeline of small molecule assets. Their approach offers a scalable, quantitative method to modulate RNA targets, positioning them uniquely in the drug discovery market with a strong scientific advisory board and leadership team.